1. Home
  2. FLS vs NUVL Comparison

FLS vs NUVL Comparison

Compare FLS & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$71.69

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$104.39

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
NUVL
Founded
1790
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FLS
NUVL
Price
$71.69
$104.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
14
Target Price
$75.50
$134.29
AVG Volume (30 Days)
1.5M
828.0K
Earning Date
10-28-2025
10-30-2025
Dividend Yield
1.17%
N/A
EPS Growth
69.42
N/A
EPS
3.44
N/A
Revenue
$4,687,417,000.00
N/A
Revenue This Year
$5.80
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
$20.80
N/A
Revenue Growth
3.19
N/A
52 Week Low
$37.34
$55.54
52 Week High
$74.63
$112.88

Technical Indicators

Market Signals
Indicator
FLS
NUVL
Relative Strength Index (RSI) 59.81 51.87
Support Level $71.10 $103.52
Resistance Level $74.63 $107.99
Average True Range (ATR) 1.78 3.18
MACD -0.30 -0.93
Stochastic Oscillator 51.01 10.43

Price Performance

Historical Comparison
FLS
NUVL

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: